Evidence map›Paper›PMID 21829516›Full record

ArticlePloS one2011

"Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.

Robert Klitzman

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. What Should We Be Asking of Informed Consent?The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2020
    Article
  4. A Qualitative Study on Experiences and Perspectives of Members of a Dutch Medical Research Ethics Committee.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. How IRBs view and make decisions about social risks.Journal of empirical research on human research ethics : JERHRE · 2013
    Article
  13. Article
  14. How IRBs view and make decisions about consent forms.Journal of empirical research on human research ethics : JERHRE · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Institutional review board community members: who are they, what do they do, and whom do they represent?Academic medicine : journal of the Association of American Medical Colleges · 2012
    Article
  19. Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.Journal of empirical research on human research ethics : JERHRE · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert KlitzmanDepartment of Psychiatry, Columbia University, New York, New York, United States of America. RLK2@columbia.edu

Funding

IRBs: Ethics, Context and InterpretationsG13LM009996 · NLM · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KLITZMAN, ROBERT L · 2009 to 2011
$240k
NLM NIH HHS 5-G13-LM009996-02NLM NIH HHS G13 LM009996PHS HHS R01-NG04214
6 · The paper itself

Abstract

unlabelledConflicts of interest (COIs) in research have received increasing attention, but many questions arise about how Institutional Review Boards (IRBs) view and approach these.

methodsI conducted in-depth interviews of 2 hours each with 46 US IRB chairs, administrators, and members, exploring COI and other issues related to research integrity. I contacted leaders of 60 IRBs (every fourth one among the top 240 institutions by NIH funding), and interviewed IRB leaders from 34 of these institutions (response rate = 55%). Data were analyzed using standard qualitative methods, informed by Grounded Theory.

resultsIRBs confront financial and non-financial COIs of PIs, institutions, and IRBs themselves. IRB members may seek to help, or compete with, principal investigators (PIs). Non-financial COI also often appear to be "indirect financial" conflicts based on gain (or loss) not to oneself, but to one's colleagues or larger institution. IRBs faced challenges identifying and managing these COI, and often felt that they could be more effective. IRBs' management of their own potential COI vary, and conflicted members may observe, participate, and/or vote in discussions. Individual IRB members frequently judge for themselves whether to recuse themselves. Challenges arise in addressing these issues, since institutions and PIs need funding, financial information is considered confidential, and COI can be unconscious.

conclusionsThis study, the first to explore qualitatively how IRBs confront COIs and probe how IRBs confront non-financial COIs, suggests that IRBs face several types of financial and non-financial COIs, involving themselves, PIs, and institutions, and respond varyingly. These data have critical implications for practice and policy. Disclosure of indirect and non-financial COIs to subjects may not be feasible, partly since IRBs, not PIs, are conflicted. Needs exist to consider guidelines and clarifications concerning when and how, in protocol reviews, IRB members should recuse themselves from participating, observing, and/or voting.

Indexed as

Conflict of InterestBiomedical ResearchDisclosureEthics Committees, ResearchFemaleHumansMaleOrganizational PolicyResearch DesignSurveys and QuestionnairesUnited States

Identifiers

PMID21829516
PMCPMC3146515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.